Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

This study has been terminated.
(Funding agent withdrew funding)
Sponsor:
Collaborators:
GE Healthcare
The Methodist Hospital System
Information provided by (Responsible Party):
Angel Augusto Rodriguez, MD, The Methodist Hospital System
ClinicalTrials.gov Identifier:
NCT02067416
First received: February 17, 2014
Last updated: September 12, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)